Sales rise 17.25% to Rs 825.35 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 25.96% to Rs 112.97 crore in the quarter ended December 2018 as against Rs 89.69 crore during the previous quarter ended December 2017. Sales rose 17.25% to Rs 825.35 crore in the quarter ended December 2018 as against Rs 703.91 crore during the previous quarter ended December 2017. ParticularsQuarter EndedDec. 2018Dec. 2017% Var.Sales825.35703.91 17 OPM %16.6420.15 -PBDT153.69153.76 0 PBT141.65140.38 1 NP112.9789.69 26Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
